These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Clinical Course and Outcome in Pediatric Idiopathic Chronic Anterior Uveitis. Kouwenberg CV; Wennink RAW; Shahabi M; Bozkir I; Ayuso VK; de Boer JH Am J Ophthalmol; 2022 Sep; 241():198-205. PubMed ID: 35513031 [TBL] [Abstract][Full Text] [Related]
30. Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented? Tan AN; Cornelissen MF; Webers CAB; Erckens RJ; Berendschot TTJM; Beckers HJM Acta Ophthalmol; 2018 Feb; 96(1):24-30. PubMed ID: 28921906 [TBL] [Abstract][Full Text] [Related]
31. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Quartier P; Baptiste A; Despert V; Allain-Launay E; Koné-Paut I; Belot A; Kodjikian L; Monnet D; Weber M; Elie C; Bodaghi B; Ann Rheum Dis; 2018 Jul; 77(7):1003-1011. PubMed ID: 29275333 [TBL] [Abstract][Full Text] [Related]
32. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Kaçmaz RO; Kempen JH; Newcomb C; Gangaputra S; Daniel E; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Jabs DA; Foster CS; Am J Ophthalmol; 2008 Dec; 146(6):828-36. PubMed ID: 18708181 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Yu EN; Meniconi ME; Tufail F; Baltatzis S; Foster CS Ocul Immunol Inflamm; 2005; 13(5):353-60. PubMed ID: 16419420 [TBL] [Abstract][Full Text] [Related]
34. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Vitale AT; Graham E; de Boer JH Ocul Immunol Inflamm; 2013 Dec; 21(6):478-85. PubMed ID: 23957455 [TBL] [Abstract][Full Text] [Related]
35. Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Kapur R; Birnbaum AD; Goldstein DA; Tessler HH; Shapiro MJ; Ulanski LJ; Blair MP Retina; 2010 Jan; 30(1):140-5. PubMed ID: 19823108 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis. Papadopoulou M; Zetterberg M; Oskarsdottir S; Andersson Grönlund M Acta Ophthalmol; 2017 Nov; 95(7):741-747. PubMed ID: 28205413 [TBL] [Abstract][Full Text] [Related]
38. Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study. Westfall AC; Lauer AK; Suhler EB; Rosenbaum JT J Glaucoma; 2005 Feb; 14(1):3-10. PubMed ID: 15650597 [TBL] [Abstract][Full Text] [Related]
39. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant. Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937 [TBL] [Abstract][Full Text] [Related]
40. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Kalinina Ayuso V; Ten Cate HA; van der Does P; Rothova A; de Boer JH Am J Ophthalmol; 2010 Jun; 149(6):994-999.e5. PubMed ID: 20510688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]